Elevated LDL-cholesterol level predicts diabetes in centrally obese women but not men - Relative roles of insulin resistance and central obesity

Circulation Journal

Volumn 71, Issue 9, 2007, Pages 1463-1467

  Onat, Altan ^a,b,e   Hergenç, Gülay ^c   Sari, Ibrahim ^d   Karabulut, Ahmet ^d   Can, Günay ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c YILDIZ TECHNICAL UNIVERSITY   (Turkey)

^d DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^e NONE   (Turkey)

Author keywords

Abdominal obesity; Diabetes type 2; Familial combined hyperlipidemia; Hypercholesterolemia; Insulin resistance; Sex difference

Indexed keywords

ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL OBESITY; ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; FAMILIAL DISEASE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; INSULIN RESISTANCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT IDENTIFICATION; PHENOTYPE; PROSPECTIVE STUDY; SEX DIFFERENCE;

ABDOMEN; ADIPOSITY; ADULT; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCHOLESTEROLEMIA; INSULIN RESISTANCE; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; OBESITY; PREDICTIVE VALUE OF TESTS; SEX FACTORS; TURKEY;

EID: 34548485581     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.1463     Document Type: Article

References (26)

1. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. Diabetes, blood lipids and the role of obesity in coronary heart disease risk for women. Ann Intern Med 1977; 87: 393- 397.
2. Barrett-Connoe E, Grundy SM, Holdbrook MJ. Plasma lipids and diabetes mellitus in an adult community. Am J Epidemiol 1982; 115: 657- 663.
3. Uusitupa M, Siitonen O, Voutilainen E, Aro A, Hersio K, Pyörälä K, et al. Serum lipids and lipoproteins in newly diagnosed non-insulin-dependent (type II) diabetic patients, with special reference to factors influencing HDL-cholesterol and triglyceride levels. Diabetes Care 1986; 9: 17- 22.
4. Howard BV, Knowler WC, Vasquez B, Kennedy AL, Pettitt DJ, Bennett PH. Plasma and lipoprotein cholesterol and triglyceride in the Pima Indian population: Comparison of diabetics and nondiabetics. Arterioclerosis 1984; 4: 462-471.
5. Howard BV. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987; 28: 613-628.
6. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal obesity and overall obesity in predicting type 2 diabetes among men. Am J Clin Nutr 2005; 81: 555-563.
7. Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: Importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab 2004; 89: 2601-2607.
8. van der Kallen CJH, Voors-Pette C, de Bruin TWA. Abdominal obesity and expression of familial combined hyperlipidemia. Obes Res 2004; 12: 2054-2061.
9. Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis 2001; 156: 1-10.
10. Onat A, Avci GŞ, Şenocak M, Örnek E, Gözükara Y. Plasma lipids and their interrelation in Turkish adults. J Epidem Commun Health 1992; 46: 470-476.
11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
12. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus: The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003; 26: 3160-3167.
13. Onat A, Avci GŞ, Barlan MM, Uyarel H, Uzunlar B, Sansoy V. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes 2004; 28: 1018-1025.
14. Onat A, Uyarel H, Hergenç G, Karabulut A, Albayrak S, Can G. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: A prospective cohort study. Atherosclerosis 2007; 191: 182-190.
15. Veerkamp MJ, de Graaf J, Hendriks JCM, Demacker PNM, Stalenhoef AFH. Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study. Circulation 2004; 109: 2980-2985.
16. McNeely MJ, Edwards KL, Marcovina SM, Brunzell JD, Motulsky AG, Austin MA. Lipoprotein and apolipoprotein abnormalities in familial combined hyperlipidemia: A 20-year prospective study. Atherosclerosis 2001; 159: 471-491.
17. Hopkins PN, Heiss G, Ellison RC, Province MA, Pankow JS, Eckfeldt JH, et al. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: A case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study. Circulation 2003; 108: 519-523.
18. Onat A, Hergenç G, Türkmen S, Yazici M, Sari İ, Can G. Discordance between insulin resistance and metabolic syndrome: Features and associated cardiovascular risk in adults with normal glucose regulation. Metabolism 2006; 55: 445-452.
19. Mykkänen L, Kuusisto J, Pyörälä K, Laakso M. Cardiovascular disease risk factors as predictors of type 2 (non-insulin- dependent) diabetes mellitus in elderly subjects. Diabetologia 1993; 36: 553-559.
20. Wang JJ, Qiao Q, Miettinen ME, Lappalainen J, Hu G, Tuomilehto J. The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a Chinese population with high postprandial glucose. Diabetes Care 2004; 27: 2429-2437.
21. D'Agostino RB Jr, Hamman RF, Karter AJ, Mykkänen L, Wagenknecht LE, Haffner SM; Insulin Resistance Atherosclerosis Study Investigators. Cardiovascular disease risk factors predict the development of type 2 diabetes: The Insulin Resistance Atherosclerosis Study. Diabetes Care 2004; 27: 2234-2240.
22. Veerkamp MJ, de Graaf J, Stalenhoef AF. Role of insulin resistance in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 2005; 25: 1026-1031.
23. Mittendorfer B. Insulin resistance: Sex matters. Curr Opin Clin Nutr 2005; 8: 367-372.
24. Nakanishi N, Shiraishi T, Wada M. C-reactive protein concentration is more strongly related to metabolic syndrome in women than in men: The Minoh Study. Circ J 2005; 69: 386-381.
25. Ban Y, Koba S, Tsunoda F, Yokota Y, Ezumi H, Kondo T, et al. Predominance of small dense low-density lipoproteins and abnormal glucose regulation in patients with acute coronary syndrome. Circ J 2006; 70: 393-401.
26. Virtanen KA, Iozzo P, Hallsten K, Huupponen R, Parkkola R, Janatuinen T, et al. Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes: A positron-emitting tomography study. Diabetes 2005; 54: 2720-2726.